Calidi Biotherapeutics

About:

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Website: https://calidibio.com

Twitter/X: calidibio

Top Investors: California Institute for Regenerative Medicine, Jackson Investment Group, Calidi Cure, Greentable Co., Ltd.

Description:

Calidi Biotherapeutics is a company that creates oncolytic virus-based immunotherapies to treat difficult-to-treat malignancies. The company focuses in immunotherapies developed using patented technology for the effective delivery of oncolytic viruses for targeted therapy, allowing healthcare practitioners to provide patients with innovative cancer treatments.

Total Funding Amount:

$76M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)calidibio.com

Founders:

Allan Camaisa

Number of Employees:

11-50

Last Funding Date:

2024-11-14

IPO Status:

Public

Industries:

© 2025 bioDAO.ai